secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celldex Therapeutics, Inc. (CLDX)
CIK:        0000744218
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001104659-22-071880
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Celldex shareholders elect all director nominees, ratify auditor, approve executive compensation at 2022 annual meeting
--------------------------------------------------------------------------------

- All 8 director nominees elected; Karen L. Shoos received 39.9M votes for, 1.0M withheld.
- Ratification of PricewaterhouseCoopers as auditor for FY2022 approved with 43.3M votes for.
- Advisory say-on-pay approved: 40.0M for, 717k against, 180k abstain.
- Broker non-votes of 2.5M shares on director election and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744218/000110465922071880/0001104659-22-071880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744218/000110465922071880/tm2218670d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-071880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer